GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Synergy Pharmaceuticals Inc (SGYP) [hlAlert]

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company?s lead drug candidate is SP-304, a guanylyl cyclase C (GC-C) receptor agonist, to treat GI disorders, primarily chronic constipation (CC)
and constipation-predominant irritable bowel syndrome (IBS-C). SP-304 is an analog of uroguanylin, a natural GI hormone secreted in the gut, which is a key regulator of intestinal function. As of December 31, 2009, the Company was developing SP-304, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. SP-304 is an agonist of GC-C. In February, 2010, a Phase IIa 14-day, repeated-oral-dose trial of SP-304 in CC patients opened for enrollment and was actively recruiting patients.
.
( Total: 6 Current Stock Recommendations )
Synergy Pharmaceuticals Inc   (6)
Buy 100%
Related companies
Show  

Date (ET)MemberRatingYTD
Gains
 
5/13/2011  
Buy
  
6/17/2013  
Buy
  
6/21/2013  
Buy
  
8/12/2013  
Buy
  
6/18/2015  
Buy
  
10/29/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy